MedPath

GALT PHARMACEUTICALS, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

FDA:4

Drug Approvals

Oravig

Approval Date
Jan 8, 2024
FDA

Norgesic

Approval Date
Jan 8, 2024
FDA

DORAL

Approval Date
Jan 31, 2023
FDA

ORPHENGESIC FORTE

Approval Date
Jan 5, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.